Activated T Cells Induce Macrophages to Produce NO and Control Leishmania Major in the Absence of Tumor Necrosis Factor Receptor P55

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2000 Feb 26

PMID 10678956

Citations 18

Authors

M Nashleanas

P Scott

Affiliations

Soon will be listed here.

Abstract

The ability to activate macrophages in vitro for nitric oxide production and killing of Leishmania major parasites is dependent on tumor necrosis factor, although L. major-infected mice lacking the TNF receptor p55 (TNFRp55(-/-) mice) or both the TNFRp55 and TNFRp75 (TNFRp55p75(-/-) mice) are able to produce NO in vivo and eliminate the parasites. Here we report that activated T cells cocultured with macrophages results in TNFR-independent activation sufficient to control parasites and that both CD40/CD40L and LFA-1 contribute to T-cell-mediated macrophage activation. Thus, anti-CD3-stimulated T cells activated TNFR-deficient macrophages, while T cells from CD40L(-/-) mice were partially defective in triggering NO production by TNFRp55p75(-/-) macrophages. Moreover, in the presence of gamma interferon, anti-CD40 monoclonal antibody (MAb) activated TNFR-deficient macrophages. Finally, MAb blockade of LFA-1 completely inhibited macrophage NO production. Our data indicate that T cells can activate macrophages in the absence of TNF, thus providing a mechanism for how TNFR-deficient mice can control intracellular pathogens.

Citing Articles

Arsenic exposure to mouse visceral leishmaniasis model through their drinking water linked to the disease exacerbation via modulation in host protective immunity: a preclinical study.

Ahmed G, Jamal F, Tiwari R, Singh V, Rai S, Chaturvedi S Sci Rep. 2023; 13(1):21461.

PMID: 38052913 PMC: 10698031. DOI: 10.1038/s41598-023-48642-z.

The cytokine/chemokine response in /HIV infection and co-infection.

Maksoud S, Hokayem J Heliyon. 2023; 9(4):e15055.

PMID: 37082641 PMC: 10112040. DOI: 10.1016/j.heliyon.2023.e15055.

Chronic lipopolysaccharide induces adverse myocardial infarction wound healing through activation of CD8 T cells.

Zaidi Y, Corker A, Vasileva V, Oviedo K, Graham C, Wilson K Am J Physiol Heart Circ Physiol. 2021; 321(5):H948-H962.

PMID: 34597184 PMC: 8616607. DOI: 10.1152/ajpheart.00082.2021.

Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy.

Morris E, Neelapu S, Giavridis T, Sadelain M Nat Rev Immunol. 2021; 22(2):85-96.

PMID: 34002066 PMC: 8127450. DOI: 10.1038/s41577-021-00547-6.

The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma.

Wei J, Liu Y, Wang C, Zhang Y, Tong C, Dai G Signal Transduct Target Ther. 2020; 5(1):134.

PMID: 32728035 PMC: 7388484. DOI: 10.1038/s41392-020-00256-x.

References

Green L, Wagner D, Glogowski J, Skipper P, Wishnok J, Tannenbaum S . Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982; 126(1):131-8. DOI: 10.1016/0003-2697(82)90118-x. View

Tushinski R, Oliver I, Guilbert L, Tynan P, Warner J, Stanley E . Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell. 1982; 28(1):71-81. DOI: 10.1016/0092-8674(82)90376-2. View

Titus R, Kelso A, Louis J . Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon. Clin Exp Immunol. 1984; 55(1):157-65. PMC: 1535781. View

Nacy C . Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes. J Immunol. 1984; 133(1):448-53. View

Sypek J, Panosian C, Wyler D . Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction. J Immunol. 1984; 133(6):3351-7. View

Jackson P, Pappas M, Hansen B . Fluorogenic substrate detection of viable intracellular and extracellular pathogenic protozoa. Science. 1985; 227(4685):435-8. DOI: 10.1126/science.2578226. View

Takei F . Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J Immunol. 1985; 134(3):1403-7. View

Belosevic M, Davis C, Meltzer M, Nacy C . Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. J Immunol. 1988; 141(3):890-6. View

Scott P, Natovitz P, Coffman R, Pearce E, Sher A . Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med. 1988; 168(5):1675-84. PMC: 2189120. DOI: 10.1084/jem.168.5.1675. View

10.

STOUT R, Bottomly K . Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. J Immunol. 1989; 142(3):760-5. View

11.

Titus R, Sherry B, Cerami A . Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med. 1989; 170(6):2097-104. PMC: 2189541. DOI: 10.1084/jem.170.6.2097. View

12.

Green S, Meltzer M, Hibbs Jr J, Nacy C . Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol. 1990; 144(1):278-83. View

13.

Liew F, Parkinson C, Millott S, Severn A, Carrier M . Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis. Immunology. 1990; 69(4):570-3. PMC: 1385631. View

14.

Liew F, Millott S, Parkinson C, Palmer R, Moncada S . Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol. 1990; 144(12):4794-7. View

15.

Bogdan C, Moll H, Solbach W, Rollinghoff M . Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur J Immunol. 1990; 20(5):1131-5. DOI: 10.1002/eji.1830200528. View

16.

Green S, Crawford R, Hockmeyer J, Meltzer M, Nacy C . Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol. 1990; 145(12):4290-7. View

17.

Castle B, Kishimoto K, Stearns C, Brown M, Kehry M . Regulation of expression of the ligand for CD40 on T helper lymphocytes. J Immunol. 1993; 151(4):1777-88. View

18.

Suttles J, Miller R, Tao X, STOUT R . T cells which do not express membrane tumor necrosis factor-alpha activate macrophage effector function by cell contact-dependent signaling of macrophage tumor necrosis factor-alpha production. Eur J Immunol. 1994; 24(8):1736-42. DOI: 10.1002/eji.1830240803. View

19.

Binnerts M, van Kooyk Y, Simmons D, Figdor C . Distinct binding of T lymphocytes to ICAM-1, -2 or -3 upon activation of LFA-1. Eur J Immunol. 1994; 24(9):2155-60. DOI: 10.1002/eji.1830240933. View

20.

Semnani R, Nutman T, Hochman P, Shaw S, van Seventer G . Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T cells. J Exp Med. 1994; 180(6):2125-35. PMC: 2191787. DOI: 10.1084/jem.180.6.2125. View